Clinical, Laboratory, and Treatment Outcome Characteristics of Chronic Lymphocytic Leukemia (CLL) Patients with p53 Mutations or del(17p) Enrolled on a Prospective Phase III Clinical Trial: Short Progression Free Survival, Irrespective of Fludarabine-Based Treatment Used.
Year: 2004
Type: article
Source: Blood
Authors: David M. Lucas, Gordon W. Dewald, Donna S. Neuberg, John C. Byrd, Gerard Lozanski, Jennifer Harbison, Kammy D. Cunningham, Ian W. Flinn, Martin S. Tallman, Michael R. Grever
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2525972189